— Know what they know.
Not Investment Advice

CBDS OTC

Cannabis Sativa, Inc.
1W: -4.8% 1M: +17.3% 3M: -33.6% 1Y: +26.1% 3Y: -75.0% 5Y: -95.4%
$0.03
Last traded 2025-06-09 — delisted
OTC · Healthcare · Medical - Healthcare Information Services · $4.3M mcap · 89M float · 0.679% daily turnover · Short 41% of daily vol

Balance Sheet Trends

Total Assets
$2M +30.2% ▲
5Y CAGR: -7.1%
Total Liabilities
$2M +22.7% ▲
5Y CAGR: +7.4%
Shareholders Equity
-$29K +98.0% ▲
Cash & Investments
$30K -91.6% ▼
5Y CAGR: -43.6%
Total Debt
$433K +19.7% ▲
5Y CAGR: -18.6%
Net Debt
$403K +23.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$194K$97K$84K$35K$30K
Short-Term Investments$209K$380K$66K$317K$0
Cash & ST Investments$403K$477K$150K$352K$30K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$10K$0$915K
Total Current Assets$403K$477K$160K$352K$945K
Property, Plant & Equip.$2K$42K$2K$2K$2K
Goodwill & Intangibles$2M$2M$2M$1M$1M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$2M$56K$75K$76K$1K
Total Non-Current Assets$2M$2M$2M$1M$1M
Total Assets$3M$3M$2M$2M$2M
— Liabilities —
Accounts Payable$95K$248K$165K$149K$0
Short-Term Debt$1M$260K$280K$362K$433K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$5K$10K$153K$407K
Total Current Liabilities$2M$470K$485K$716K$840K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$418K$778K$1M$1M
Total Non-Current Liabilities$0$428K$778K$1M$1M
Total Liabilities$2M$898K$1M$2M$2M
— Equity —
Common Stock$31K$46K$89K$144K$160K
Retained Earnings-$79M-$81M-$82M-$84M-$84M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$293K$382K-$602K-$1M-$29K
Total Liabilities & Equity$3M$3M$2M$2M$2M
— Key Metrics —
Total Debt$1M$299K$290K$362K$433K
Net Debt$1M$202K$206K$327K$403K
Total Investments$209K$380K$66K$317K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms